Yangzhou Su

1.3k total citations · 1 hit paper
4 papers, 994 citations indexed

About

Yangzhou Su is a scholar working on Molecular Biology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yangzhou Su has authored 4 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 1 paper in Otorhinolaryngology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Yangzhou Su's work include RNA Interference and Gene Delivery (1 paper), Advanced biosensing and bioanalysis techniques (1 paper) and Immunotherapy and Immune Responses (1 paper). Yangzhou Su is often cited by papers focused on RNA Interference and Gene Delivery (1 paper), Advanced biosensing and bioanalysis techniques (1 paper) and Immunotherapy and Immune Responses (1 paper). Yangzhou Su collaborates with scholars based in China, Saudi Arabia and United States. Yangzhou Su's co-authors include Suye Zhong, Yongguang Tao, Cong Li, Chao Chen, Junjun Yang, Bang Liu, Yiqun Jiang, Zuping He, Jie Dai and Meiling Zhou and has published in prestigious journals such as Science Advances, Signal Transduction and Targeted Therapy and Cancer Immunology Immunotherapy.

In The Last Decade

Yangzhou Su

4 papers receiving 987 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes: key players in cancer and potential therapeutic strategy

2020 899 citations Jie Dai, Yangzhou Su et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yangzhou Su China	2	861	514	132	129	87	4	994
Suye Zhong China	5	871 1.0×	519 1.0×	134 1.0×	131 1.0×	96 1.1×	7	1.0k
Victor Ma China	9	889 1.0×	491 1.0×	101 0.8×	166 1.3×	90 1.0×	16	1.0k
Chuanshi He China	11	716 0.8×	420 0.8×	120 0.9×	171 1.3×	68 0.8×	17	902
Yaying Hao China	7	661 0.8×	397 0.8×	113 0.9×	128 1.0×	51 0.6×	10	797
Luyen Tien Vu Singapore	9	813 0.9×	454 0.9×	130 1.0×	151 1.2×	53 0.6×	11	910
Maarten P. Bebelman Netherlands	10	887 1.0×	509 1.0×	162 1.2×	111 0.9×	74 0.9×	16	1.0k
Tin Chanh Pham Hong Kong	7	774 0.9×	403 0.8×	156 1.2×	166 1.3×	101 1.2×	8	928
Johann Mar Gudbergsson Denmark	10	1.3k 1.5×	724 1.4×	122 0.9×	234 1.8×	62 0.7×	16	1.4k
Xiaomou Wei China	9	737 0.9×	461 0.9×	181 1.4×	106 0.8×	70 0.8×	14	876
Boya Peng China	15	1.2k 1.4×	580 1.1×	193 1.5×	261 2.0×	99 1.1×	25	1.5k

Countries citing papers authored by Yangzhou Su

Since Specialization

Citations

This map shows the geographic impact of Yangzhou Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangzhou Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangzhou Su more than expected).

Fields of papers citing papers by Yangzhou Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangzhou Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangzhou Su. The network helps show where Yangzhou Su may publish in the future.

Co-authorship network of co-authors of Yangzhou Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yangzhou Su. A scholar is included among the top collaborators of Yangzhou Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangzhou Su. Yangzhou Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Liang, Haifeng, Jing Tian, Yangzhou Su, et al.. (2025). Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study. Cancer Immunology Immunotherapy. 74(3). 108–108. 1 indexed citations

2.

Xue, Zhaoyu, Mengying Huang, Ling Xie, et al.. (2024). A potent and selective ENL degrader suppresses oncogenic gene expression and leukemia progression. Science Advances. 10(35). eado1432–eado1432. 1 indexed citations

3.

Zhou, Meiling, Suye Zhong, Yangzhou Su, et al.. (2022). The role of cell‐penetrating peptides in potential anti‐cancer therapy. Clinical and Translational Medicine. 12(5). e822–e822. 93 indexed citations

4.

Dai, Jie, Yangzhou Su, Suye Zhong, et al.. (2020). Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduction and Targeted Therapy. 5(1). 145–145. 899 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact